India Patent Cases
2,847 decisions indexed
Page 71 of 95 · 2,847 total
Kannur Lulu Sarees And Textiles Pvt. Ltd v.The Controller General Of Patents, Designs and Trademarks Office of the Trade Marks Registry
The Kerala High Court dismissed a Writ Petition filed by Kannur Lulu Sarees And Textiles Pvt. Ltd against various IP authorities, including The Controller General of Patents and Designs. The petitioner sought leave to withdraw the case, which was subsequently granted by the court. This dismissal allows the petitioner to pursue their rights through other appropriate legal channels.
Kanishk Sinha v.Union Of India
The petitioner challenged the validity of a patent by questioning the vires of Section 64 of the Patents Act. The Union of India admitted the stand taken by the petitioner in its affidavit-in-opposition, leading the Calcutta High Court to dispose of the writ petition.
Torque Pharmaceuticals Private Limited v.Emami Limited
This order sheet details an application filed by Emami Limited seeking the transfer of a title suit from the Additional District Judge to the Calcutta High Court. The original suit involved allegations of infringement concerning trademark, passing off, copyright, and design against Torque Pharmaceuticals Private Limited. Citing Clause 13 of the Letters Patent, 1865, and Section 22(4) of the Designs Act, 2000, the court allowed the transfer application.
Astrazeneca Ab & Anr. v.Jigs Chemicals Limited
Astrazeneca sued Jigs Chemicals Limited for infringing its patents covering the anti-platelet drug TICAGRELOR. The plaintiffs claimed that the defendant was commercially advertising and offering to sell API TICAGRELOR. Based on the defendant's admission regarding the exclusive rights under Section 48 of the Patents Act, the court granted summary judgment in favor of Astrazeneca.
Japan Tobacco v.D.Jhamnadas
This Delhi High Court order addresses a complex dispute between Japan Tobacco and D.Jhamnadas, involving multiple IP claims. While the defendant relies on their registered trademark 'CAMEL,' the plaintiff asserts claims based on copyright and passing off. The court allowed the suit to proceed despite the pending Supreme Court appeal regarding the trademark registration, directing both parties to file detailed written submissions.
Genentech Inc And Others v.Drugs Controller General Of India And Others
This case involves an application by Defendant No. 3 seeking to restrict the participation of the plaintiffs' internal expert, Dr. Samir Sagitrao, in the inspection of confidential clinical and pre-clinical test data related to a biosimilar drug. The court ultimately dismissed the applicant's request, emphasizing that defendants have a right to defend the suit without being deprived of opportunity due to non-disclosure.
Radico Khaitan Limited v.Union Of India & Anr
This Delhi High Court judgment addresses a dispute over the exclusive use of the geographical name 'GOA' in relation to gin. Following a partial rectification by the Intellectual Property Appellate Board (IPAB), which limited exclusivity only to the label mark, Radico Khaitan Limited challenged this decision. The court issued an interim order staying the IPAB's judgment, clarifying that the partial rectification does not grant public domain status to the word 'GOA,' thereby protecting the petitioner's statutory rights against third-party misuse.
Telefonaktiebolaget Lm Ericsson (Pub) v.Gionee Communication Equipment Co. Ltd & Anr
The Delhi High Court passed an order in a patent infringement suit concerning several Ericsson patents related to 2G, EDGE, and 3G technology. The court framed issues regarding whether the patents are Standard Essential Patents (SEPs), whether there is infringement by Gionee, and whether the plaintiff complied with FRAND commitments.
Lupin Ltd. v.Union Of India And Ors.
Lupin Ltd. challenged the NPPA's stance that it should have sought prior permission before launching an FDC drug (Empagliflozin and Metformin Hydrochloride), relying on a product patent exemption under Para 32(i) of DPCO, 2013. The court recognized the legal ambiguity regarding whether prior approval or mere intimation is required to avail this exemption.
Cde Asia Limited v.Jaideep Shekhar & Anr.
Cde Asia Limited filed a suit seeking permanent injunction against Jaideep Shekhar and others for infringing its patent (No. 307249) and registered design (No. 262629) related to material classification systems used in mining and sand aggregate production. The defendant challenged the plaint, arguing that the suit was premature as it was filed before the one-year period required for post-grant opposition under Section 25(2) of the Patents Act had lapsed. Additionally, the defense contested the court's territorial jurisdiction. The High Court dismissed the application challenging the plaint, allowing the infringement suit to proceed.
Roche Products (India) Private Limited v.Cadila Healthcare Limited
The plaintiffs, including Roche Products and F. Hoffmann-La Roche, challenged the validity of drug approvals granted by the DCGI and DoB to Cadila Healthcare Ltd. for its biosimilar product 'Trastuzumab'. The core legal issue was whether the suit was maintainable given the regulatory framework, specifically concerning appeal provisions under the Drugs Rules.
M/s.ADD PRINT [INDIA] ENTERPRISES PRIVATE LIMITED v.M/S.LAMBA MARKETING SYSTEMS AND M/S.LAMBA STAMPS AND SIGNS
This civil suit was filed alleging infringement of the plaintiff's registered trademarks ('SUN STAMPER') and designs (Box type pre inked rubber Stamp, Reg. No. 207586) by the defendants using 'STAMP ONE'. The plaintiff sought perpetual injunctions and damages against the alleged infringers. However, despite multiple opportunities to depose its witness over a period of nearly twelve years, the plaintiff failed to appear in court.
Novartis Ag v.Sun Pharmaceutical Industries Ltd
The plaintiffs own the patent for the compound 'NILOTINIB', which is valid until July 4, 2023. The defendant announced the launch of a product based on NILOTINIB, which the plaintiffs claim infringes their patent.
Trulines Technologies Through Ashish Kuashikbhai Patel v.State Of Gujarat
Trulines Technologies challenged the investigation process, arguing that the machines were not analyzed by a government-recognized expert qualified under the Patent Act. The court examined the validity of the existing report and the expertise of the person who conducted the examination.
Kanishk Sinha v.The State Of West Bengal & Ors.
Kanishk Sinha filed a title suit seeking accounts, delivery of products, and permanent/mandatory injunction against defendants for infringing his patent rights related to eco-friendly e-rikshaws. The trial court dismissed the application for temporary injunction on grounds including lack of territorial jurisdiction and failure to comply with Section 80(2) CPC. This appeal challenged the impugned order.
Essdee Industries Through Proprietor Sridhar Velangi v.Esbee Electrotech LLP
This Civil Writ Petition was filed by Essdee Industries against Esbee Electrotech LLP, challenging a previous court order. The impugned order allowed the respondent/plaintiff to conditionally withdraw their composite suit, granting them the liberty to file two separate suits concerning alleged trademark and design infringement of their rights. The Bombay High Court proceeded with issuing notice in this appeal.
The Indian Express (P) Ltd. And 2 Others v.Prashant Goenka And 11 Others
The Bombay High Court addressed a contempt petition alleging breach of an interim order concerning the use of 'INDIAN EXPRESS' trademarks and Ramnath Goenka's copyrighted photographs. After the respondents unconditionally apologized for the inadvertent breaches, the court directed digital platforms (YouTube and Facebook) to remove specified infringing URLs. The primary contempt petition was thus disposed of, while a separate application seeking rejection of the plaint against one defendant was remanded for further hearing.
Bristol-Myers Squibb Holdings Ireland Unlimited Company & Ors. v.Bdr Pharmaceuticals International Pvt. Ltd. & Anr.
The plaintiffs, owners of Patent IN-381 covering the molecule APIXABAN (Eliquis®), filed a suit against Bdr Pharmaceuticals for allegedly manufacturing and intending to supply generic versions of this patented drug. The court considered arguments regarding infringement and the validity of the patent based on prior art documents submitted by the defendant.
M/s.Taranga Technologies v.M/s.Neels Enterprises Pvt. Ltd.
The appeal was filed against an order dismissing an application seeking to revoke leave granted in a suit for infringement of registered design and passing off. The core dispute revolved around whether the appellant's involvement in a national tender, which included supply within Chennai jurisdiction, provided sufficient grounds for the court to exercise territorial jurisdiction.
Galatea Ltd. v.Sahajanand Technologies Private Limited
Galatea Ltd. filed an application arguing that the trial court failed to appoint a local commissioner to inspect premises and inventory alleged infringing evidence related to patent infringement. The petitioners contended that notice alone risked the destruction or removal of evidence. The High Court agreed, granting the application for the appointment of seven commissioners.
Galatea Ltd. Through Authorised Signatory Saira Rana v.M. Kantilal Exports
Galatea Ltd. filed an application seeking the appointment of a court commissioner for local inspection and inventory regarding alleged patent infringement, arguing that issuing notice would lead to the removal or destruction of evidence. The Court agreed with the petitioners' apprehension and granted the application.
Bristol Myers Squibb Holdings Ireland Unlimited Company v.Natco Pharma
Plaintiffs filed a suit seeking permanent injunction against Natco Pharma for infringing Indian Patent No.IN247381 (APIXABAN). The defendant sought a stay under Section 10 CPC, citing a previously instituted suit in the City Civil Court at Hyderabad concerning patent validity and infringement. The High Court dismissed the stay application.
Boehringer Ingelheim Pharma GmbH & Co.KG v.Tanmed Pharma India Private Limited
Boehringer Ingelheim Pharma sued Tanmed Pharma for infringing its patents related to the medicinal product Linagliptin. The court conducted an inspection and found that the defendant had neither manufactured nor marketed the drug, having surrendered its manufacturing license.
Astrazeneca Ab v.Emcure Pharmaceuticals Limited
Astrazeneca sued Emcure Pharmaceuticals Limited and MSN Laboratories Limited for infringing their patents related to the pharmaceutical compound TICAGRELOR, marketed as BRILINTA. The plaintiffs sought an interim injunction against the defendants' generic versions (TICAPLAT and TIARE).
Shalina Laboratories Private Limited v.Maxwell Life Science Pvt. Ltd.
The Bombay High Court confirmed the existing interim injunctions granted to Shalina Laboratories against Maxwell Life Science. The dispute centered on trademark infringement ('SUPER APETI' vs 'SUPER PEPTI'), copyright infringement related to packaging/trade dress, and passing-off concerning pharmaceutical preparations. By confirming these orders, the court maintained the status quo, ensuring the Plaintiff's rights were protected while the main commercial IP suit proceeds.
All India Patent Officers Welfare Association v.Union Of India & Ors
The All India Patent Officers Welfare Association filed a petition alleging that the Controller General of Patents, Designs and Trademarks (CGPDTM) unlawfully provided access to sensitive, unpublished trademark and patent application data to a private multinational company. The petitioner argued this access lacked necessary checks and balances. The Delhi High Court accepted the petition and directed an investigation into the matter, setting a timeline for the respondents to file their reply.
Narendra Singh v.Ashendra Mishra
Narendra Singh filed an application seeking the appointment of an independent arbitrator under the Arbitration and Conciliation Act, 1996, against Ashendra Mishra regarding disputes arising from their partnership firm, M/s. Kautilya Academy. The applicant alleged misuse of the trade mark and siphoning of funds by the respondents. However, the court dismissed the application, holding that since there were serious allegations of forgery, fraud, and dispute over the very execution of the partnership deed, the matter was not fit for arbitration. The proper remedy was directed to be sought in a civil court.
Deepak Nitrite Limited v.Sara Chemicals & Consultants
Deepak Nitrite Limited sought an urgent ad-interim injunction against Sara Chemicals & Consultants, alleging that Sara Chemicals had unilaterally filed five patent applications based on a proprietary process developed by Deepak Nitrite. The Petitioner argued that the relevant data and technology belonged exclusively to them, and there was a risk of third-party disclosure.
Mr Imran Aman Sharieff (IAS Enterprises) v.M/s Sathwika Traders; M/s Sri Tarakarama Rice Industries
The Karnataka High Court remanded an appeal concerning a dispute over trademark and copyright infringement. The appellant, Mr. Imran Aman Sharieff, sought to overturn the trial court's rejection of his application for a temporary injunction. Crucially, he introduced a new document—an order rejecting the respondents' trade mark registration application—at the appellate stage. The High Court ruled that since this new evidence was not available during the initial proceedings, it could only be used by directing the trial court to reconsider its decision based on the newly produced material.
Anand S/o Nanabhau Embadwar v.Union of India, Through Ministry of Agricultural & Farmers Welfare
This case involved a Public Interest Litigation and Writ Petition challenging the manufacturing and marketing of Soil Testing Fertilizer Recommendation (STFR) technology developed by ICAR and IARI. The petitioner, Nagarjuna Agro Chemicals Pvt. Ltd., sought to restrain its marketing while simultaneously benefiting from the technology. The court found the litigation frivolous and vexatious.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.